#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Von Hippel-Lindau disease Laryngeal squamous cell carcinoma Transient ischaemic attack Fallopian tube cancer Metastatic malignant melanoma Skin angiosarcoma Thrombotic microangiopathy Craniopharyngioma Brain injury Juvenile psoriatic arthritis Diffuse large B-cell lymphoma Haemophilia B with anti factor IX Plasma cell myeloma Multifocal motor neuropathy Familial hypertriglyceridaemia More trials…

    Learn about Rare Diseases

    Gaucher’s disease type I Wolfram syndrome – Life with Disease Mucopolysaccharidosis I – Treatment Rosai-Dorfman syndrome – Trials in Disease Pemphigoid – Life with Disease Mucopolysaccharidosis II – Diagnostics Pleomorphic leiomyosarcoma – Diagnostics Burkitt’s lymphoma – Basic Information Synovial sarcoma – Basic Information Prolymphocytic leukaemia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    INCB123667 Glucose, Anhydrous Alectinib Hydrochloride Rusfertide Ipatasertib Crgd-Zw800-1 Alks 2680 Trimetazidine Dihydrochloride Foscarnet Belatacept ALENDRONATE SODIUM TRIHYDRATE SONLICROMANOL HYDROCHLORIDE Ontasameran HYDROMORPHONE HYDROCHLORIDE Dolutegravir Sodium Cloxacillin NVG-2089 Azilsartan Medoxomil Magnesium Iomeprol More therapies…

    Learn about Your Condition

    Leiomyosarcoma recurrent Seasonal allergy Upper limb fracture Addison's disease Acquired ATTR amyloidosis Intracranial aneurysm Pterygium Neurotrophic keratopathy Synovitis Thrombosis Brain cancer metastatic Cholangitis sclerosing Tardive dyskinesia Hepatorenal syndrome Thrombotic microangiopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

HIV infection

  • Study of Bictegravir and Lenacapavir for Children and Adolescents with HIV-1

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Bictegravir
    • Lenacapavir
    Italy Spain

  • Study of Emtricitabine, Tenofovir Alafenamide and Bictegravir in Adults with HIV Undergoing Analytical Treatment Interruption

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Emtricitabine
    • Tenofovir Alafenamide
    Spain

  • Safety and Efficacy of Dasatinib in Reducing HIV-1 Reservoir, Inflammation, and Immune Senescence in People with HIV on Long‑Term Antiretroviral Therapy

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Dasatinib
    Spain

  • Study on the Safety and Immune Response of the 9-Valent HPV Vaccine in Women Living with HIV

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Human Papillomavirus Type 11 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 16 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 18 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    Belgium

  • Study of Weekly Oral GS-1720 and GS-4182 for People with HIV-1 Who Are Virologically Suppressed

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • GS-1720
    • Gs-4182
    • Bictegravir
    France Germany Italy Poland Spain Sweden

  • Study on Doravirine and Raltegravir for Maintaining Viral Control in HIV Patients with Low Viral Load

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Doravirine
    • Raltegravir
    France Italy Spain
Previous Page
1 2 3 4 5 6 … 12
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!